|
EIF3E expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.818200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.416400E-02 |
| Normal-vs-Stage2 |
3.603600E-01 |
| Normal-vs-Stage3 |
4.987900E-02 |
| Normal-vs-Stage4 |
4.804400E-03 |
| Stage1-vs-Stage2 |
5.246400E-02 |
| Stage1-vs-Stage3 |
9.170800E-04 |
| Stage1-vs-Stage4 |
2.136100E-03 |
| Stage2-vs-Stage3 |
4.088200E-01 |
| Stage2-vs-Stage4 |
9.915800E-03 |
| Stage3-vs-Stage4 |
3.477000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.311800E-01 |
| Normal-vs-AfricanAmerican |
6.870600E-01 |
| Normal-vs-Asian |
3.375200E-01 |
| Caucasian-vs-AfricanAmerican |
8.199400E-01 |
| Caucasian-vs-Asian |
9.458000E-02 |
| AfricanAmerican-vs-Asian |
3.053200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.501450E-01 |
| Normal-vs-Female |
3.156100E-02 |
| Male-vs-Female |
1.630910E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.642400E-01 |
| Normal-vs-Extreme_Weight |
3.041600E-01 |
| Normal-vs-Obese |
3.536000E-01 |
| Normal-vs-Extreme_Obese |
1.169810E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.118400E-01 |
| Normal_Weight-vs-Obese |
6.875600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.174580E-01 |
| Extreme_Weight-vs-Obese |
9.303800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.791200E-01 |
| Obese-vs-Extreme_Obese |
1.126390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.587900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.861200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.091020E-01 |
| Normal-vs-Age(81-100Yrs) |
6.460200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.964300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.673950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.113600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.168000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.289600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.881200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.019300E-03 |
| Normal-VS-Type2 PRCC |
2.368600E-01 |
| Normal-VS-KIRP CIMP |
1.377490E-03 |
| Normal-VS-Unclassified PRCC |
7.650800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.383700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.179300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.581700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.242420E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.628800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.78789999999629E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.237800E-01 |
| Normal-vs-N1 |
4.798800E-04 |
| Normal-vs-N2 |
4.671900E-02 |
| N0-vs-N1 |
2.637000E-04 |
| N0-vs-N2 |
2.245400E-04 |
| N1-vs-N2 |
4.683200E-01 |
|
|
